Skip to content
MedsAcross

Medicine

Naproxen and Sumatriptan 500 mg/85 mg tablet

Available on requestPrescription onlyUS FDAGeneric name

Naproxen and Sumatriptan 500 mg/85 mg tablet is a generic prescription medicine for oral use, made by 4 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° and 30°C…

Key facts

Active ingredient (INN)
Naproxen and Sumatriptan
Brand
Sold under the generic name
Strength
500 mg/85 mg
Dosage form
Tablet
Route
Oral
Packs
9 tablets, 30 tablets, 100 tablets and 3 more
Manufacturers
Sun Pharmaceutical IndustriesIndiaAurobindo PharmaIndiaCypress, Hawthorn, MacovenNorthStar RxLLC
Origin register
US FDA, United States
Storage
Store at 20° to 25°C (68° to 77°F), excursions permitted between 15° and 30°C (59° and 86°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
14 May 2015
Identifiers
RxCUI 849450DailyMed set ID 3f2ec27e-0e96-4028-a1fa-114e6d501464, f5203c66-0a40-4263-a237-b71e930e4697, 96ed12a3-fa76-4afd-bee8-1ab19eb607f3 +1NDC 16714-891, 65862-928, 47335-410 +1Application ANDA202803, ANDA207457, NDA021926

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
9 tablet, film coated in 1 bottle65862-928-36Aurobindo PharmaIndia15 February 2018
9 tablet, film coated in 1 bottle47335-410-22Sun Pharmaceutical IndustriesIndia20 July 2018
30 tablet, film coated in 1 bottle47335-410-83Sun Pharmaceutical IndustriesIndia20 July 2018
100 tablet, film coated in 1 bottle47335-410-88Sun Pharmaceutical IndustriesIndia20 July 2018
9 tablet in 1 bottle44183-850-09Cypress, Hawthorn, Macoven15 February 2018
9 tablet, film coated in 1 bottle16714-891-01NorthStar RxLLC27 November 2018

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 15 April 2008Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Naproxen and Sumatriptan 500 mg/85 mg tablet.

Compare 1

Clinical summary

Naproxen and Sumatriptan is a fixed-dose combination of a nonsteroidal anti-inflammatory drug and a serotonin-1b and serotonin-1d receptor agonist indicated for the acute treatment of migraine, among other approved uses. MedsAcross supplies Naproxen and Sumatriptan for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Naproxen and Sumatriptan

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Naproxen and Sumatriptan 500 mg/85 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.